U.S. FDA Issues Warning Letter To Glenmark For Lapses At Goa Plant
[ad_1] The U.S. Food and Drug Administration flagged various lapses, including failure to establish required laboratory control mechanisms, at Glenmark Pharmaceuticals Ltd.’s Goa-based manufacturing plant. The regulator inspected the company’s…